The ratings agency also lowered the rating on the health system’s series 2008B refunding variable-rate hospital bonds to “AA+/A-1+” from “AAA/A-1+.”
“The downgrade reflects our view of GHS’s weaker operating performance over the past couple of years and our expectation of potentially lighter-than-historical margins,” said S&P analyst Margaret McNamara. “GHS has invested heavily over the past several years in information technology and to prepare the organization for population health. This has placed pressure on margins and key balance-sheet metrics.”
The outlook is stable, reflecting S&P Global Ratings’ assessment of the health system’s leading business position, adequate financial profile and ongoing strategic investment in service lines and physician integration.
More articles on healthcare finance:
14 recent hospital outlook and credit rating actions
Moody’s affirms ‘A2’ rating on Southeast Georgia Health System’s bonds
Moody’s affirms ‘Aa1’ rating on Children’s Hospital & Medical Center’s LOC-backed bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
